On Demand 2017 Friday General Sessions
This collection covers general sessions from Friday's program. This includes plenaries, and symposia. The sessions listed below are included in this package:
- Mastocytosis/Mast Cell Activation Syndrome: Demystifying MCAS - Clearing the Muddy Waters
- Special Seminar: What's New in Health Care
- Chronic Rhinosinusitis: Translating Studies Innate Immunity/Barrier Function & Inflammatory Endotypes to Treatment Paradigms for Patients
- Childhood Asthma
- World Allergy Forum: State of the Art on the Management of Atopic Dermatitis
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 8.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medical professionals who treat patients with allergic and/or immunological conditions:
- Practicing allergist/immunologists
- Allergy/immunology Fellows-in-Training
- Physician assistants
- Nurses and advanced practice nurses
- Allied health professionals
- Primary care physicians
- Other medical professionals
Upon completion of this session, participants should be able to:
- Examine basic immunology of innate, adaptive and mucosal host defense mechanisms.
- Apply these facts to identify targets for new, novel treatment strategies.
- Design appropriate history, physical, laboratory and imaging studies to allow precision medicine therapeutic plans to be developed for chronic hyperplastic sinusitis.
- Differentiate key signs and symptoms of HAE from other common conditions and review the HAE complement profile.
- Review the role of the complement cascade in HAE attacks.
- Discuss the role of bradykinin receptors in HAE attacks and potential pathophysiologic explanations for multi-site attacks.
- Illustrate the appropriate historical and physical manifestations of chronic sinusitis and accompanying comorbidities.
- Design the appropriate laboratory evaluation to confirm the diagnosis of mastocytosis from mast cell activation syndrome.
- Evaluate treatment options for MCAS and mastocytosis.
- Jay Lieberman, MD, FACAAI
- Cem Akin, MD
- Lawrence B. Schwartz, MD, FACAAI
- Mariana C. Castells, MD, PhD, FACAAI
- David M. Lang, MD, FACAAI
- Eli O. Meltzer, MD, FACAAI
- Robert Schleimer, MD, PhD
- Tanya M. Laidlaw, MD
- Daniel L. Hamilos, MD
- Todd A. Mahr, MD, FACAAI
- Leonard B. Bacharier, MD, FACAAI
- Stanley Szefler, MD
- Mario Sanchez-Borges, MD
- Stephen A. Tilles, MD, FACAAI
- Lanny J. Rosenwasser, MD, FACAAI
- Marcella R. Aquino, MD, FACAAI
- John J. Oppenheimer, MD, FACAAI
- 8.50 AMA PRA Category 1 Credit™
- 8.50 Attendance
- 3.00 MOC